Amy Banse - 28 Mar 2024 Form 4 Insider Report for CLOROX CO /DE/ (CLX)

Role: Director
Signature: By Cheryl Brice, Attorney-in-Fact for
Issuer symbol: CLX
Transactions as of: 28 Mar 2024
Net transactions value: +$26,182
Form type: 4
Filing time: 02 Apr 2024, 18:31:26 UTC
Previous filing: 01 Mar 2024
Next filing: 11 Apr 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CLX	Common Stock	Award	$26,182	+171		$153.11	171	28 Mar 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CLX	Deferred Stock Units	Award	$0	+61	+0.78%	$0.000000	7,904	09 Feb 2024	Common Stock	61		Direct	F2, F3, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Receipt of Common Stock in lieu of quarterly director's fee.
F2	1-for-1
F3	Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan.
F4	The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director.